EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Maternal–fetal platelet alloimmunization: Identification of risk factors for severe neonatal thrombocytopenia

Elise Deroubaix iD, Marie-Hélène Emektas, Gauthier Alluin, Pascale Renom, Fanny Rodermann, Mélissa Gilbert, Charles Garabedian, Véronique Houfflin-Debarge

Transfusion · 2026-07 · 66 (7) · 1316-1325

DOI: 10.1111/trf.70234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, online erschienen am 25.05.2026. Verfasst von Elise Deroubaix und 7 weiteren Autor:innen. Beteiligte Einrichtung: CHU Lille, Pôle mère femme et nouveau-né, Lille, France. Hauptthemen laut MEDLINE: Thrombocytopenia, Neonatal Alloimmune, Blood Platelets. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Feto‐maternal platelet alloimmunization (FNAIT) is a rare condition (1 in 1500 live pregnancies), most commonly diagnosed based on clinical neonatal hemorrhagic manifestations, which can vary in severity. The aim of our study was to identify risk factors for severe fetal/neonatal thrombocytopenia in cases of FNAIT. Materials and Methods A retrospective study from 1993 to 2022 of pregnancies characterized by FNAIT. Data collected included patient characteristics, management of the pregnancies, and neonatal characteristics. Comparisons regarding pregnancy management and neonatal data were made between “index cases” and “subsequent pregnancies,” as well as between neonates with severe thrombocytopenia and those with no thrombocytopenia or moderate thrombocytopenia.

Results

Seventy‐one patients were included in our study, corresponding to 119 pregnancies. Mothers of neonates with severe thrombocytopenia had a higher history of previous pregnancies characterized by severe neonatal thrombocytopenia (100.0% vs. 75.9%, p = .03). The FNAIT mainly involved the anti‐HPA‐1a system (75.0% vs. 54.5%, p = .02), and fewer treatments with IVIG were administered during pregnancy (6.6% vs. 34.1%, p < .001).

Conclusion

FNAIT must be identified and appropriately managed to limit its potentially dramatic consequences, including fetal/neonatal death. Based on the patient's history, risk stratification for the occurrence of severe FNAIT in future pregnancies should be performed to tailor its management accordingly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thrombocytopenia, Neonatal AlloimmuneBlood PlateletsHumansFemalePregnancyInfant, NewbornRisk FactorsRetrospective StudiesAdultAntigens, Human Platelet

Stichwörter der Autor:innen

anti‐platelet alloantibodiesfetal and neonatal alloimmune thrombocytopeniafetal/neonatal intracranial hemorrhagefetal/neonatal thrombocytopeniaintravenous polyvalent immunoglobulins

Substanzen

Antigens, Human Platelet

Autor:innen und Institutionen

  • CHU Lille, Pôle mère femme et nouveau-né, Lille, France.
  • Laboratoire d'immunohématologie, Etablissement français du sang Hauts-de-France-Normandie, Lille, France.
  • Univ. Lille, ULR 2694-METRICS: Évaluation des technologies de santé et des pratiques médicales, Lille, France.

ORCID-Profile: Elise Deroubaix

Zitieren

APA

Deroubaix, E., Emektas, M. H., Alluin, G., Renom, P., Rodermann, F., Gilbert, M., Garabedian, C., & Houfflin-Debarge, V. (2026). Maternal–fetal platelet alloimmunization: Identification of risk factors for severe neonatal thrombocytopenia. Transfusion, 66(7), 1316-1325. https://doi.org/10.1111/trf.70234

Vancouver

Deroubaix E, Emektas MH, Alluin G, Renom P, Rodermann F, Gilbert M, et al. Maternal–fetal platelet alloimmunization: Identification of risk factors for severe neonatal thrombocytopenia. Transfusion. 2026;66(7):1316-1325. doi:10.1111/trf.70234

BibTeX
@article{Deroubaix2026,
  author = {Deroubaix, Elise and Emektas, Marie-Hélène and Alluin, Gauthier and Renom, Pascale and Rodermann, Fanny and Gilbert, Mélissa and Garabedian, Charles and Houfflin-Debarge, Véronique},
  title = {Maternal–fetal platelet alloimmunization: Identification of risk factors for severe neonatal thrombocytopenia},
  journal = {Transfusion},
  year = {2026},
  volume = {66},
  number = {7},
  pages = {1316--1325},
  doi = {10.1111/trf.70234}
}
Kostenlos starten →